Compare, Analyse Jubilant Pharmova with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    ACTAVIS
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
ACTAVIS
Dec-18
JUBILANT PHARMOVA /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs72714,350-   
Low Rs2309,626-   
Sales per share (Unadj.) Rs574.73,520.0-  
Earnings per share (Unadj.) Rs56.4-1,133.8-  
Cash flow per share (Unadj.) Rs85.4370.9-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.814,518.5-  
Shares outstanding (eoy) m159.28332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.83.4 24.4%   
Avg P/E ratio x8.5-10.6 -80.3%  
P/CF ratio (eoy) x5.632.3 17.3%  
Price / Book Value ratio x1.40.8 164.7%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,2203,987,197 1.9%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m21,2770-   
Avg. sales/employee Rs ThNM69,276.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,313.8-  
INCOME DATA
Net Sales Rs m91,5441,170,764 7.8%  
Other income Rs m47422,389 2.1%   
Total revenues Rs m92,0181,193,153 7.7%   
Gross profit Rs m19,12430,680 62.3%  
Depreciation Rs m4,619500,476 0.9%   
Interest Rs m2,87467,560 4.3%   
Profit before tax Rs m12,105-514,967 -2.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0131,337 0.0%   
Tax Rs m3,123-6,526 -47.9%   
Profit after tax Rs m8,982-377,104 -2.4%  
Gross profit margin %20.92.6 797.2%  
Effective tax rate %25.81.3 2,035.7%   
Net profit margin %9.8-32.2 -30.5%  
BALANCE SHEET DATA
Current assets Rs m50,383480,186 10.5%   
Current liabilities Rs m26,190424,788 6.2%   
Net working cap to sales %26.44.7 558.5%  
Current ratio x1.91.1 170.2%  
Inventory Days Days720 33.3%  
Debtors Days Days5266 77.8%  
Net fixed assets Rs m72,721132,524 54.9%   
Share capital Rs m1590-   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,0394,828,854 1.2%   
Long term debt Rs m37,3971,700,415 2.2%   
Total assets Rs m123,1047,548,598 1.6%  
Interest coverage x5.2-6.6 -78.7%   
Debt to equity ratio x0.70.4 189.5%  
Sales to assets ratio x0.70.2 479.5%   
Return on assets %9.6-4.1 -234.9%  
Return on equity %16.0-7.8 -205.3%  
Return on capital %16.0-4.8 -331.2%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,429418,270 3.7%  
From Investments Rs m-3,270229,785 -1.4%  
From Financial Activity Rs m-10,504-717,876 1.5%  
Net Cashflow Rs m2,254-69,473 -3.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.16 Rs / USD

Compare JUBILANT PHARMOVA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: SMS PHARMA  NGL FINE CHM  JAGSON PHAR  PARENT.DRUGS  UNICHEM LAB  



Today's Market

Sensex, Nifty Open Higher; TCS & Tata Steel Top Gainers(09:30 am)

Asian share markets are mixed today as investors reassessed US Federal Reserve statements on inflation and focused on upcoming data for direction.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

More Views on News

Most Popular

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

Cut the Noise and Hold these Stocks FOREVER (Profit Hunter)

Jun 17, 2021

A sure shot way of creating wealth is to not disturb the process of compounding.

Profit from the Next Leg of the Metals Rally (Fast Profits Daily)

Jun 14, 2021

I think metal stocks are set to continue their rally. Here's why...

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Jun 24, 2021 11:33 AM

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - SHREE GANESH REMEDIES COMPARISON

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS